The company offers a multidimensional service that relies on the molecular motor drug carrier platform, from drug discovery, analysis to process research, and clinical development and product registration. Drug carriers are agents that change the way drugs enter the body and distribute in the body, controlling the rate of drug release And the drug delivery system to the target organ, can reduce drug degradation and loss, reduce side effects and improve bioavailability.

In recent years, various systems such as microspheres, liposomes, and microemulsions have been studied in order to find a suitable target drug carrier. However, these materials are easily oxidized, leaked and stored in vitro. Easy degradation of some enzymes and phagocytosis of macrophages and can not reach the target tissue to play an effective role in the shortcomings of these are limiting its use as a carrier. On the other hand, the existing pharmaceutical carriers are often only passive targets due to their structural limitations and stability, or are directly linked to targeting agents and drugs, with limited use. The company through the invention of the molecular motor biosensor as a targeted drug carrier, not only through their own lipid bilayer structure wrapped drugs, but also in its special transmembrane protein on the link targeting factor, with structural stability, the package High sealing rate, low leakage, targeting and other characteristics, greatly improving the safety and efficacy of drugs.